Fat embolism syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Fat embolism syndrome}} {{CMG}} ==Overview== ==Pathophysiology== The pathogenesis of FES is not completely defined. It is thought to be caused by blockage of ...")
 
Line 11: Line 11:


The fat induces a toxic, inflammatory reaction.  This inflammatory reaction is thought to be related to the production of free fatty acids.  Studies have shown that neutral fatty acids are not toxic , however, they are hydrolyzed over many hours to substances proven to cause [[ARDS]] in animal models.  Not surprisingly, [[C-reactive protein]] is usually elevated in these patients.  Levels of [[lipoprotein lipase]], and [[free fatty acids]] ([[FFA]]) are noted in animal models.
The fat induces a toxic, inflammatory reaction.  This inflammatory reaction is thought to be related to the production of free fatty acids.  Studies have shown that neutral fatty acids are not toxic , however, they are hydrolyzed over many hours to substances proven to cause [[ARDS]] in animal models.  Not surprisingly, [[C-reactive protein]] is usually elevated in these patients.  Levels of [[lipoprotein lipase]], and [[free fatty acids]] ([[FFA]]) are noted in animal models.
===Microscopic Pathology===
[[image:ARDS.jpg|thumb|left|Acute Respiratory Distress Syndrome (ARDS)]]
<br clear="left"/>


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 15:26, 21 September 2012

Fat embolism syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fat embolism syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fat embolism syndrome pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fat embolism syndrome pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fat embolism syndrome pathophysiology

CDC on Fat embolism syndrome pathophysiology

Fat embolism syndrome pathophysiology in the news

Blogs on Fat embolism syndrome pathophysiology

Directions to Hospitals Treating Fat embolism syndrome

Risk calculators and risk factors for Fat embolism syndrome pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

The pathogenesis of FES is not completely defined. It is thought to be caused by blockage of vessels from systemic embolization of fat globules. Echocardiographic reports have demonstrated echogenic material passing through the right atrium followed by increased pulmonary pressures and right heart pressures and subsequent paradoxical embolization of this material through a patent foramen ovale (PFO).

The fat induces a toxic, inflammatory reaction. This inflammatory reaction is thought to be related to the production of free fatty acids. Studies have shown that neutral fatty acids are not toxic , however, they are hydrolyzed over many hours to substances proven to cause ARDS in animal models. Not surprisingly, C-reactive protein is usually elevated in these patients. Levels of lipoprotein lipase, and free fatty acids (FFA) are noted in animal models.

Microscopic Pathology

Acute Respiratory Distress Syndrome (ARDS)


References